Related references
Note: Only part of the references are listed.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Stiffness increases with myofibroblast content and collagen density in mesenchymal high grade serous ovarian cancer
Virginie Mieulet et al.
SCIENTIFIC REPORTS (2021)
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Fanglong Wu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins
Cedric Zeltz et al.
SEMINARS IN CANCER BIOLOGY (2020)
The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome
Elisa D'Arcangelo et al.
BRITISH JOURNAL OF CANCER (2020)
Epithelial/mesenchymal heterogeneity of high-grade serous ovarian carcinoma samples correlates with miRNA let-7 levels and predicts tumor growth and metastasis
Evgeny Chirshev et al.
MOLECULAR ONCOLOGY (2020)
Cancer-associated fibroblasts induce epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer via CXCL12/CXCR4 axis
Fang Zhang et al.
FUTURE ONCOLOGY (2020)
The extracellular matrix as a key regulator of intracellular signalling networks
Jordan F. Hastings et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer
Qinglei Gao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Cancer-associated fibroblasts in gastrointestinal cancer
Hiroki Kobayashi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Transforming Growth Factor-β Signaling in Immunity and Cancer
Eduard Batlle et al.
IMMUNITY (2019)
Biological Insights into Chemotherapy Resistance in Ovarian Cancer
Michelle A. Glasgow et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs
Yuxing Liao et al.
NUCLEIC ACIDS RESEARCH (2019)
Ovarian cancer and the evolution of subtype classifications using transcriptional profiling
David P. Cook et al.
BIOLOGY OF REPRODUCTION (2019)
Hypoxia-Inducible Factor-1α (HIF-1α) Promotes Hypoxia-Induced Invasion and Metastasis in Ovarian Cancer by Targeting Matrix Metallopeptidase 13 (MMP13)
Hui Zhang et al.
MEDICAL SCIENCE MONITOR (2019)
Parp inhibitors as maintenance treatment in platinum sensitive recurrent ovarian cancer: An updated meta-analysis of randomized clinical trials according to BRCA mutational status
Federica Tomao et al.
CANCER TREATMENT REVIEWS (2019)
Digital Immune-Related Gene Expression Signatures In High-Grade Serous Ovarian Carcinoma: Developing Prediction Models For Platinum Response
Fabian Mairinger et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Cancer-associated stroma significantly contributes to the mesenchymal subtype signature of serous ovarian cancer
Qing Zhang et al.
GYNECOLOGIC ONCOLOGY (2019)
Transcriptome Comparisons of Multi-Species Identify Differential Genome Activation of Mammals Embryogenesis
Chunshen Long et al.
IEEE ACCESS (2019)
Fibroblasts as maestros orchestrating tissue regeneration
Raquel Costa-Almeida et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2018)
TGF-beta requires the activation of canonical and non-canonical signalling pathways to induce skeletal muscle atrophy
Johanna Abrigo et al.
BIOLOGICAL CHEMISTRY (2018)
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Ana Costa et al.
CANCER CELL (2018)
CD10+ GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
Shicheng Su et al.
CELL (2018)
CAFs enhance paclitaxel resistance by inducing EMT through the IL-6/JAK2/STAT3 pathway
Linlin Wang et al.
ONCOLOGY REPORTS (2018)
EphA3 contributes to tumor growth and angiogenesis in human gastric cancer cells
Xiao-Ye Lv et al.
ONCOLOGY REPORTS (2018)
Identifying Phage Virion Proteins by Using Two-Step Feature Selection Methods
Jiu-Xin Tan et al.
MOLECULES (2018)
Tumor evolution and chemoresistance in ovarian cancer
Soochi Kim et al.
NPJ PRECISION ONCOLOGY (2018)
Gonadotropins promote human ovarian cancer cell migration and invasion via a cyclooxygenase 2-dependent pathway
Dingqing Feng et al.
ONCOLOGY REPORTS (2017)
Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection
Shomyseh Sanjabi et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
High expression of EphA3 (erythropoietin-producing hepatocellular A3) in gastric cancer is associated with metastasis and poor survival
Baongoc Nasri et al.
BMC CLINICAL PATHOLOGY (2017)
Subtypes of Ovarian Cancer and Ovarian Cancer Screening
Masafumi Koshiyama et al.
DIAGNOSTICS (2017)
Extracellular matrix component signaling in cancer
Hinke A. B. Multhaupt et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
The Dualistic Model of Ovarian Carcinogenesis Revisited, Revised, and Expanded
Robert J. Kurman et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Paracrine tumor signaling induces transdifferentiation of surrounding fibroblasts
Petr Heneberg
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ECM interactions
Jennifer Alexander et al.
CURRENT OPINION IN CELL BIOLOGY (2016)
Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions
Nicolette G. Alkema et al.
DRUG RESISTANCE UPDATES (2016)
Signaling Receptors for TGF-β Family Members
Carl-Henrik Heldin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Ovarian cancer
Ursula A. Matulonis et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
The biology and function of fibroblasts in cancer
Raghu Kalluri
NATURE REVIEWS CANCER (2016)
Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer
Clifford J. Whatcott et al.
CLINICAL CANCER RESEARCH (2015)
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
Amit M. Oza et al.
LANCET ONCOLOGY (2015)
Invasion of ovarian cancer cells is induced byPITX2-mediated activation of TGF-β and Activin-A
Moitri Basu et al.
MOLECULAR CANCER (2015)
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
David D. Bowtell et al.
NATURE REVIEWS CANCER (2015)
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
Berna C. Oezdemir et al.
CANCER CELL (2014)
Analysis and identification of essential genes in humans using topological properties and biological information
Lei Yang et al.
GENE (2014)
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
Eric Pujade-Lauraine et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer
Gottfried E. Konecny et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Analysis and identification of toxin targets by topological properties in protein-protein interaction network
Lei Yang et al.
JOURNAL OF THEORETICAL BIOLOGY (2014)
PSMD9 expression predicts radiotherapy response in breast cancer
Fiona E. Langlands et al.
MOLECULAR CANCER (2014)
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
Roel G. W. Verhaak et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer
Emma L. Barber et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2013)
Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer
Miriam Lenhard et al.
BMC CANCER (2012)
Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness
Jing Cai et al.
CARCINOGENESIS (2012)
Increased Expression of PITX2 Transcription Factor Contributes to Ovarian Cancer Progression
Frederic K. C. Fung et al.
PLOS ONE (2012)
Recent Progress in the Diagnosis and Treatment of Ovarian Cancer
Danijela Jelovac et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The dynamic roles of TGF-beta in cancer
Erik Meulmeester et al.
JOURNAL OF PATHOLOGY (2011)
Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent Manner
Neta Erez et al.
CANCER CELL (2010)
Activation of fibroblasts in cancer stroma
Kati Rasanen et al.
EXPERIMENTAL CELL RESEARCH (2010)
The polarization of immune cells in the tumour environment by TGFβ
Richard A. Flavell et al.
NATURE REVIEWS IMMUNOLOGY (2010)
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
Pierre Farmer et al.
NATURE MEDICINE (2009)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA
Matt K. Lee et al.
EMBO JOURNAL (2007)
Optimizing primary chemotherapy in ovarian cancer
M Markman
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2003)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
